176 related articles for article (PubMed ID: 22340436)
1. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
2. BAFF is up-regulated in central nervous system of neuro-Behçet's disease.
Hamzaoui K; Houman H; Hentati F; Hamzaoui A
J Neuroimmunol; 2008 Aug; 200(1-2):111-4. PubMed ID: 18625522
[TBL] [Abstract][Full Text] [Related]
3. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
4. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
5. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
7. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
[TBL] [Abstract][Full Text] [Related]
10. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.
Hirohata S; Kikuchi H
Intern Med; 2012; 51(24):3359-65. PubMed ID: 23257520
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.
Taşçi B; Direskeneli H; Serdaroglu P; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
Clin Exp Immunol; 1998 Jul; 113(1):100-4. PubMed ID: 9697991
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
14. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
Braun T; Juenemann M; Dornes K; El-Shazly J; Schramm P; Bick-Ackerschott S; Kaps M; Gerriets T; Blaes F; Tschernatsch M
Int J Neurosci; 2021 Dec; 131(12):1231-1236. PubMed ID: 32602764
[TBL] [Abstract][Full Text] [Related]
15. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
16. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Status in patients with Neuro-Behçet's disease.
Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
[TBL] [Abstract][Full Text] [Related]
18. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
Niino M; Ogata A; Kikuchi S; Tashiro K; Nishihira J
J Neurol Sci; 2000 Oct; 179(S 1-2):127-31. PubMed ID: 11054496
[TBL] [Abstract][Full Text] [Related]
20. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment.
Borhani-Haghighi A; Kardeh B; Banerjee S; Yadollahikhales G; Safari A; Sahraian MA; Shapiro L
Mult Scler Relat Disord; 2020 Apr; 39():101906. PubMed ID: 31887565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]